Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Rajesh Jain Ph.D. | Chairman of the Board & MD | 9.01M | -- | 1964 |
| Mr. Sandeep Jain | Joint MD & Executive Director | 8.37M | -- | 1966 |
| Mr. Devender Gupta | CFO & Head of Information Technology | -- | -- | 1973 |
| Dr. Khalid Al Syed | Chief Scientific Officer | -- | -- | 1975 |
| Mr. Vinod Goel | Group CFO, Head of Legal, Company Secretary & Compliance Officer | -- | -- | 1965 |
| Mr. Ankesh Jain | Whole-Time Director | 3.03M | -- | 1988 |
| Dr. Rajeeva Kumar Mangalum | Chief Operating Officer | -- | -- | 1961 |
| Naresh Chand Gupta | General Manager of Accounts & Taxation | -- | -- | -- |
| Mr. Ashish Jain | Chief Information Officer | -- | -- | -- |
| Mr. Gurinder Pal Singh | Senior Vice President of Sales | -- | -- | 1967 |
Panacea Biotec Limited
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1,936
Description
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as transplantation, renal disease, oncology, respiratory, pain management, diabetes and cardiovascular management, gastro-intestinal care, nephrology, osteoporosis management, orthopedics, pain management, and fever; and betacoronavirus, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, hepatitis A, and varicella vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V; Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc for the manufacture and supply of Azacitidine injection; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Corporate Governance
Upcoming Events
February 11, 2025 at 10:59 AM UTC - February 15, 2025 at 12:00 PM UTC
Panacea Biotec Limited Earnings Date
Recent Events
September 19, 2011 at 12:00 AM UTC
Ex-Dividend Date